Recent Quotes (30 days)

You have no recent quotes
chg | %

Telesta Therapeutics Inc  

(Public, TSE:TST)   Watch this stock  
Find more results for TST
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 0.04 - 1.00
Open     -
Vol / Avg. 0.00/720,905.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 0.01
Shares 303.51M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun. '16) 2016
Net profit margin - 28.83%
Operating margin - 26.55%
EBITD margin - 49.15%
Return on average assets -40.04% 10.32%
Return on average equity -52.96% 22.92%
Employees 53 -
CDP Score - -


231 Dundas Street East
+1-514-5876148 (Phone)
+1-514-6977966 (Fax)

Website links


Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.